Cargando…
EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway
Doxorubicin (DOX), the first-line chemotherapy for bladder cancer, usually induces side effects. We previously demonstrated that green tea polyphenol EGCG had potent anti-tumor effect in bladder cancer via down regulation of NF-κB. This study aimed to investigate the additive/synergistic effect EGCG...
Autores principales: | Luo, Ke-Wang, Zhu, Xiao-hong, Zhao, Ting, Zhong, Jin, Gao, Han-chao, Luo, Xin-Le, Huang, Wei-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793730/ https://www.ncbi.nlm.nih.gov/pubmed/33425912 http://dx.doi.org/10.3389/fcell.2020.606123 |
Ejemplares similares
-
PAQR3 Inhibits Non-small Cell Lung Cancer Growth by Regulating the NF-κB/p53/Bax Axis
por: Guo, Qiang, et al.
Publicado: (2020) -
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
por: Qi, Si-Min, et al.
Publicado: (2020) -
It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
por: Kung, Che-Pei, et al.
Publicado: (2022) -
BRCC3 Promotes Tumorigenesis of Bladder Cancer by Activating the NF-κB Signaling Pathway Through Targeting TRAF2
por: Tao, Huangheng, et al.
Publicado: (2021) -
The MDM2 Single-Nucleotide Polymorphism T309G Is Associated With the Development of Epimacular Membranes
por: Jiang, Heng, et al.
Publicado: (2022)